Work

Clinical outcome of taxane-resistant (TR) hormone refractory prostate cancer (HRPC) patients (pts) treated with subsequent chemotherapy (ixabepilone (Ix) or mitoxantrone/prednisone (MP)

Year: 2006

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2006.24.18_suppl.4558

Authors: A. M. Lin, J. E. Rosenberg, V. K. Weinberg, W. K. Kelly, M. D. Michaelson, M. Hussain, G. Wilding, M. E. Gross, E. J. Small

Institutions: Cedars-Sinai Medical Center, University of Wisconsin–Madison, University of California, San Francisco, University of Michigan, Yale University

Language: English

Topic: Prostate Cancer Treatment and Research

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W3011769359

Cites:

Cited by: 13

Related to: 10